IP Library › Granted Patent US 8,101,380
Granted Patent B2
US 8,101,380 · App. 12/593,159 · Granted Jan 24, 2012

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

Assignee: The United States of America as represented by the Secretary of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,380
App. No.
12/593,159
Granted
Jan 24, 2012
Kind
B2
Abstract

The invention is related to a novel primate specific brain isoform of the potassium channel KCNH2 and genetic association with risk for schizophrenia.

Claims (14)

1. An isolated nucleic acid molecule encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:27 and SEQ ID NO:28.

2. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid encodes the polypeptide comprising the amino acid sequence of SEQ ID NO: 5.

3. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid encodes the polypeptide of SEQ ID NO: 27 or SEQ ID NO: 28.

4. An isolated nucleic acid molecule comprising a polynucleotide sequence of SEQ ID NO:3.

5. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:27 and SEQ ID NO:28.

6. The isolated polypeptide of claim 5 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 5.

7. The isolated polypeptide of claim 5 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 27 or SEQ ID NO: 28.

8. A recombinant vector comprising a nucleic acid molecule selected from the group consisting of:

i) a nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:27 and SEQ ID NO:28; and,

ii) a nucleic acid molecule comprising the polynucleotide sequence of SEQ ID NO:3.

9. A recombinant host cell comprising a recombinant vector comprising a nucleic acid molecule selected from the group consisting of:

i) a nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:27 and SEQ ID NO:28; and,

ii) a nucleic acid molecule comprising the polynucleotide sequence of SEQ ID NO:3.

10. A method of making a polypeptide selected from the group consisting of SEQ ID NO:5, SEQ ID NO:27 and SEQ ID NO:28 comprising culturing a host cell of claim 9 under conditions such that the polypeptide is expressed.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2009
From: WEINBERGER, DANIEL R.; HUFFAKER, STEPHEN; KLEINMAN, JOEL E.; LU, BAI
To: THE USA AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
Reel/Frame 023723/0102 →
Continuity (2)
Provisional Application 60920220 · Mar 26, 2007
Related Publication 20100105623A1 · Apr 29, 2010